CandlesenseCandlesense
News/Companies/SHPH

SHPH News

Shuttle Pharma Provides Second Quarter 2025 Corporate Update

SHPH

GAITHERSBURG, Md., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today provided a corporate update.

August 14, 2025Update
Read more →

Shuttle Pharma Board Approves Proposed Reverse Stock Split Of Common Stock At Ratio Of 25-For-1

SHPH

June 12, 2025
Read more →

Shuttle Pharma Announces The Appointment Of George Scorsis As The Chairman Of The Board Of Directors

SHPH

June 4, 2025
Read more →

Shuttle Pharma Announces FDA Orphan-Drug Nears Patient Enrollment Milestone For Phase 2 Clinical Trial

SHPH

May 8, 2025
Read more →

Shuttle Pharmaceuticals Has Been Granted A European Patent Titled DUAL FUNCTION MOLECULES FOR HISTONE DEACETYLASE INHIBITION AND ATAXIA TELANGIECTASIA MUTATED ACTIVATION (FOR TREATMENT OF CANCERS, NEUROLOGICAL DISORDERS, & IMMUNOLOGICAL DISORDERS)

SHPH

May 7, 2025
Read more →

Shuttle Pharmaceuticals Announces Filing Of Key Provisional Patent Application With The United States Patent And Trademark Office Entitled PSMA-Targeted PARP Inhibitor Conjugates for Precision Cancer Therapy

SHPH

April 10, 2025
Read more →

Shuttle Pharma Announces Pricing Of $5.75M Underwritten Offering Of 19,166,667 Shares Of Its Common Stock At A Public Offering Price Of $0.30 Per Share

SHPH

March 12, 2025
Read more →

Shuttle Pharmaceuticals Appoints Christopher Cooper As Interim Co-CEO

SHPH

March 12, 2025
Read more →

Shuttle Pharmaceuticals Provides Corporate Update On Phase 2 Glioblastoma Trial Enrollment, Diagnostics Advancements With UCSF, Launch Of New Corporate Website, And $237,500 Investment By CEO Dr. Anatoly Dritschilo And Other Investors In Recent Financing

SHPH

February 26, 2025
Read more →

Shuttle Pharmaceuticals FY24 EPS $(3.30) Vs $(3.53) YoY

SHPH

February 26, 2025
Read more →

Shuttle Pharma Enters Sponsored Research Agreement With University of California, San Francisco To Advance PSMA Development Program

SHPH

December 19, 2024
Read more →

Shuttle Pharmaceuticals Shares Resume Trade Following Circuit Breaker Halt, Stock Now Down 8.8%

SHPH

September 12, 2022
Read more →

Shuttle Pharmaceuticals Shares Halted On Circuit Breaker

SHPH

September 12, 2022
Read more →

Shuttle Pharmaceuticals Holdings shares were trading higher amid post-IPO volatility after the stock began trading in late August.

SHPH

September 12, 2022
Read more →